Hong Kong stock surge | Sino Biopharmaceutical (01513.HK) up nearly 6% with completion of patient enrollment in Phase II clinical trial of innovative cardiovascular drug H001 capsules.

According to the Securities Times APP, Lee's Pharmaceutical (01513.HK) rose nearly 6%, as of the time of publication, up 5.96% to 34.65 Hong Kong dollars, with a turnover of 41.8711 million Hong Kong dollars.